Research output per year
Research output per year
Search results
-
2020
Erratum: Osimertinib for patients with non–small-cell lung cancer harboring uncommon EGFR mutations: A multicenter, open-label, phase II trial (KCSG-LU15-09) (Journal of Clinical Oncology (2020) DOI: 10.1200/JCO.19.00931)
Cho, J. H., Lim, S. H., An, H. J., Kim, K. H., Park, K. U., Kang, E. J., Choi, Y. H., Ahn, M. S., Lee, M. H., Sun, J. M., Lee, S. H., Ahn, J. S., Park, K. & Ahn, M. J., 10 Apr 2020, In: Journal of Clinical Oncology. 38, 11, p. 1248 1 p.Research output: Contribution to journal › Comment/debate